Abbott Laboratories, Novartis, and Grifols have reached a settlement in their long-running legal battle over a patent ...

The family that owns Spanish drugmaker Grifols and private equity firm Brookfield are considering whether to take the company private in a deal that could be worth around €5.5 billion (almost $6 ...

Private equity company Brookfield has reportedly moved closer to taking control of Grifols, after months of disruption at the Spanish pharma company. A report in Spanish newspaper El Confidencial ...

MADRID (Reuters) - U.S.-based investment fund Mason Capital said on Monday it had sent a letter to Spain's stock market regulator CNMV demanding more transparency from the embattled pharmaceutical ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF ...

In 2019, Grifols became the first pharmaceutical company in the United States to receive the Zero-Waste-to-Landfill validation from Underwriters Laboratories in recognition of the Clayton site ...

About Grifols, S.A. and Blueprint Medicines Corporation Grifols, S.A. operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally. The company provides ...

Grifols swiftly rejected the bid ... It is present in more than 30 countries including Australia, the United States and Japan. It posted revenue of 6.6 billion euros in 2023, a 10.9 percent ...

Grifols’ repository of PD plasma samples is just a fraction of the more than 100 million samples the company has collected for nearly 15 years. Its proprietary bank is one of the world’s ...